Project Grant R01HD111454
Award Date
9/18/24
Completion Date
8/31/27
Dollars Obligated
$1.9M
Funding Federal Agency
Office of the Director
Awarding Federal Agency
National Institute of Child Health and Human Development
Federal Grant Program
93.310
Assistance Type
Project Grant
Place of Performance
Charlestown, MA 02129, USA
Similar Awards
This federal Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) provides $2,357,335 to study neuronal dysfunction in Down syndrome (DS) and its link to Alzheimer's disease (AD). The key products and services delivered under this award include: Utilizing induced pluripotent stem cell (iPSC)-derived cortical organoids and assembloids to examine the cellular, transcriptomic, and motility-related...
The federal Cooperative Agreement award U01HD116463, titled "The Infant Down Syndrome Brain and Behavior Study", is funded by the National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310). The $2,927,457 award will support a longitudinal study to collect multimodal neuroimaging, cognitive/behavioral data, and social communication measures in a cohort of 100 infants with Down syndrome and 50 typically developing controls. The study aims to...
This $5.2 million project grant from the Department of Health and Human Services National Institutes of Health Office of the Director, under the Trans-NIH Research Support program, will fund research at the University of Colorado Denver to study neurovascular dysfunction in individuals with Down syndrome revealed by traumatic brain injury. Over three years, the collaborative multi-principal investigator team will establish how trisomy 21-related cellular defects and candidate genes exacerbate...
This federal Project Grant award, totaling $1,274,904.00, was provided by the National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310). The award, with a performance period from August 1, 2025 to July 31, 2027, is focused on elucidating the mechanisms by which mobilization of transposable elements and disruption of mRNA translation impact neural progenitor cell function in Down syndrome. The key objectives of this collaborative research initiative are to: 1)...
The University of Texas Southwestern Medical Center received a $451,000 Project Grant award from the National Institutes of Health (NIH) under the Trans-NIH Research Support (CFDA 93.310) program. The award, effective July 1, 2025 through June 30, 2027, will support research to identify genes on human chromosome 21 that contribute to the pathologies of Down syndrome, including reduced neurogenesis and brain size. The project aims to use CRISPR interference (CRISPRi) technology with induced...
This $866,506 Project Grant award was provided by the National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310) to the Magee-Womens Research Institute And Foundation. The award, effective from September 20, 2025 to August 31, 2027, supports the "Include Clinical Researcher Training (ICRT)" program. This program annually recruits, trains, mentors, and provides career guidance to 16 post-graduate participants dedicated to mastering Down Syndrome...
The National Institutes of Health (NIH) awarded a $446,096 Project Grant under the Trans-NIH Research Support program (CFDA 93.310) to the University of Illinois to develop and implement a community-based participatory health research project with young adults with Down syndrome. The project aims to reflect the perspectives and lived experiences of this population, including those from underserved communities, to identify factors that impede or facilitate their social, physical, and mental...
This federal Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), provides $429,000 to the Regents of the University of Michigan to conduct research on the molecular regulators of the GABAergic system in human neurons derived from control and trisomy 21 (Down syndrome) human embryonic stem cells. The primary goal is to discover the underlying mechanisms that cause...
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), through the Child Health and Human Development Extramural Research program (CFDA 93.865), awarded a $147,486 Project Grant to The Johns Hopkins University. This grant, effective September 21, 2025 through March 25, 2027, aims to investigate the role of the placenta-brain axis in Down syndrome (DS) development. Specifically, the research will examine the effects of chromosome 21 dosage, driven by the...
This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), is providing $134,730 to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to develop advanced brain imaging methods that can better distinguish between different neurological processes underlying brain maturation. The goal is to...